BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Oct 27, 2008
 |  BC Week In Review  |  Company News  |  Deals

Genentech, Nerviano deal

The companies partnered to discover antibody drug conjugates to treat cancer. Nerviano, which was spun off from Pfizer Inc. (NYSE:PFE,...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >